RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Public ClinicalTrials.gov record NCT07009860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
RESTORE TRIAL: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD.
Study identification
- NCT ID
- NCT07009860
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2025 (Actual)
- Primary completion
- Sep 30, 2027 (Estimated)
- Completion
- Sep 30, 2027 (Estimated)
- Last update posted
- Aug 17, 2026
2025 – 2027
United States locations
- U.S. sites
- 36
- U.S. states
- 15
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altimmune Clinical Study Site | Peoria | Arizona | 85381 | — |
| Altimmune Clinical Study Site | Tucson | Arizona | 85712 | — |
| Altimmune Clinical Study Site | North Little Rock | Arkansas | 72117 | — |
| Altimmune Clinical Study Site | Fresno | California | 93720 | — |
| Altimmune Clinical Study Site | La Jolla | California | 92037 | — |
| Altimmune Clinical Study Site | Pasadena | California | 91105 | — |
| Altimmune Clinical Study Site | Bradenton | Florida | 34201 | — |
| Altimmune Clinical Study Site | Doral | Florida | 33122 | — |
| Altimmune Clinical Study Site | Fort Myers | Florida | 33192 | — |
| Altimmune Clinical Study Site | Miami | Florida | 33125 | — |
| Altimmune Clinical Study Site | Miami | Florida | 33165 | — |
| Altimmune Clinical Study Site | Miami Lakes | Florida | 33122 | — |
| Altimmune Clinical Study Site | Naples | Florida | 34102 | — |
| Altimmune Clinical Study Site | Orlando | Florida | 32803 | — |
| Altimmune Clinical Study Site | Atlanta | Georgia | 30309 | — |
| Altimmune Clinical Study Site | Indianapolis | Indiana | 46202 | — |
| Altimmune Clinical Study Site | Louisville | Kentucky | 40202 | — |
| Altimmune Clinical Study Site | Bastrop | Louisiana | 71220 | — |
| Altimmune Clinical Study Site | Marrero | Louisiana | 70072 | — |
| Altimmune Clinical Study Site | West Monroe | Louisiana | 71291 | — |
| Altimmune Clinical Study Site | St Louis | Missouri | 63123 | — |
| Altimmune Clinical Study Site | Las Vegas | Nevada | 89106 | — |
| Altimmune Clinical Study Site | Manhasset | New York | 11030 | — |
| Altimmune Clinical Study Site | New York | New York | 10032 | — |
| Altimmune Clinical Study Site | Syracuse | New York | 13210 | — |
| Altimmune Clinical Study Site | Wilmington | North Carolina | 28403 | — |
| Altimmune Clinical Study Site | Westlake | Ohio | 44145 | — |
| Altimmune Clinical Study Site | Brownsville | Texas | 78520 | — |
| Altimmune Clinical Study Site | Dallas | Texas | 75390 | — |
| Altimmune Clinical Study Site | Edinburg | Texas | 78539 | — |
| Altimmune Clinical Study Site | Houston | Texas | 77030 | — |
| Altimmune Clinical Study Site | Houston | Texas | 77079 | — |
| Altimmune Clinical Study Site | San Antonio | Texas | 78215 | — |
| Altimmune Clinical Study Site | San Antonio | Texas | 78251 | — |
| Altimmune Clinical Study Site | Waco | Texas | 76710 | — |
| Altimmune Clinical Study Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07009860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07009860 live on ClinicalTrials.gov.